CARDIOMYOPATHY, SECONDARY
Clinical trials for CARDIOMYOPATHY, SECONDARY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, SECONDARY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, SECONDARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy targets deadly heart damage in rare neurological disease
Disease control OngoingThis early-stage trial is testing whether a single dose of LX2006 gene therapy can safely treat heart muscle damage in people with Friedreich's ataxia. The therapy delivers a healthy gene directly to heart cells to improve their function. Eight participants with confirmed Friedre…
Matched conditions: CARDIOMYOPATHY, SECONDARY
Phase: PHASE1, PHASE2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Global heart study aims to stop pacemakers from harming hearts
Disease control OngoingThis large international study aims to improve treatment for people receiving heart devices like pacemakers. Researchers want to identify which patients are most at risk of developing heart damage from their devices before implantation happens. By creating a personalized risk sco…
Matched conditions: CARDIOMYOPATHY, SECONDARY
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC